GlassScriptPhysician profile
Nam Keun Yoon
NPI 1194083915
$11,143.20
in general payments reported to CMS, 2019-2025
11 companies · $3,086 in 2025
The $3,086 reported for 2025 was more than what 75% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $2,124 · 2021: $2,076 · 2022: $1,226 · 2023: $634 · 2024: $1,723 · 2025: $3,086.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,339 · Travel and Lodging: $2,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,339.43 |
| Travel and Lodging | $2,103.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,509.99 | 2021-2025 | Cd Horizon Spinal System, Anteralign Spinal System With Titan Nanolock Surface Technology, Catalyft Pl Expandable Interbody System |
| Depuy Synthes Sales INC. | $2,611.78 | 2019-2025 | Cerebase, Cerepak Uniform, N/A |
| Globus Medical, INC. | $1,982.68 | 2020-2022 | |
| Microvention, INC. | $847.30 | 2020-2025 | Web Aneurysm Embolization System, Stent, Eric Retrieval Device |
| Penumbra, INC. | $423.59 | 2020-2025 | Penumbra Coil 400, Penumbra System, Benchmark |
| Medtronic USA, INC. | $248.95 | 2020 | |
| Alphatec Spine, INC | $242.87 | 2024 | Other - Miscellaneous |
| Balt USA, LLC | $135.71 | 2021-2024 | Optima Coil System |
| Si-Bone, INC. | $113.46 | 2019 | |
| Stryker Corporation | $14.02 | 2020 | |
| Brainlab, INC. | $12.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nam Yoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.